UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effects of sleep deprivation on pain inhibition and spontaneous pain in women

Sleep (New York, N.Y.), 2007-04, Vol.30 (4), p.494-505

2007

Volltextzugriff (PDF)

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

Synapse (New York, N.Y.), 2008-02, Vol.62 (2), p.91-100

2008

Volltextzugriff (PDF)

Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile

The Journal of pharmacology and experimental therapeutics, 2013-02, Vol.344 (2), p.479-488

2013

Volltextzugriff (PDF)

Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity

Drug metabolism and disposition, 2009-10, Vol.37 (10), p.2079-2086

2009

Volltextzugriff (PDF)

Platelet Serotonin Signaling in Patients With Cardiovascular Disease and Comorbid Depression

Psychosomatic medicine, 2019-05, Vol.81 (4), p.352-362

2019

Volltextzugriff (PDF)

Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses

The Journal of pharmacology and experimental therapeutics, 2008-10, Vol.327 (1), p.38-44

2008

Volltextzugriff (PDF)

Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates

The Journal of pharmacology and experimental therapeutics, 2005-10, Vol.315 (1), p.91-98

2005

Volltextzugriff (PDF)

Plasma Drug Concentrations and Physiological Measures in 'Dance Party' Participants

Neuropsychopharmacology (New York, N.Y.), 2006-02, Vol.31 (2), p.424-430

2006

Volltextzugriff (PDF)

Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal

Drug and alcohol dependence, 2011-08, Vol.117 (1), p.38-44

2011

Volltextzugriff (PDF)

Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance

Psychopharmacologia, 2008-10, Vol.200 (3), p.439-450

2008

Volltextzugriff (PDF)

Recognition and management of complications of new recreational drug use

Lancet, 2005-06, Vol.365 (9477), p.2137-2145

2005

Volltextzugriff (PDF)

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

Addiction (Abingdon, England), 1994-05, Vol.89 (5), p.539-551

1994

Volltextzugriff (PDF)

Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [ C]McN5652 and [ C]DASB

Neuropsychopharmacology (New York, N.Y.), 2005-09, Vol.30 (9), p.1741-1750

2005

Volltextzugriff (PDF)

Amphetamine neurotoxicity: accomplishments and remaining challenges

Neuroscience and biobehavioral reviews, 2004, Vol.27 (8), p.821-826

2004

Volltextzugriff (PDF)

Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers

Neurology, 2009-12, Vol.73 (23), p.2011-2017

2009

Volltextzugriff (PDF)

Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428

The Journal of neuroscience, 1998-10, Vol.18 (20), p.8417-8422

1998

Volltextzugriff (PDF)

Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery

The Journal of neuroscience, 1999-06, Vol.19 (12), p.5096-5107

1999

Volltextzugriff (PDF)

Severe Dopaminergic Neurotoxicity in Primates after a Common Recreational Dose Regimen of MDMA ("Ecstasy")

Science (American Association for the Advancement of Science), 2002-09, Vol.297 (5590), p.2260-2263

2002

Volltextzugriff (PDF)

Single oral doses of (±) 3,4-methylenedioxymethamphetamine (‘Ecstasy’) produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations

The international journal of neuropsychopharmacology, 2013-05, Vol.16 (4), p.791-801

2013

Volltextzugriff (PDF)

Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences

The Journal of pharmacology and experimental therapeutics, 2011-07, Vol.338 (1), p.310-317

2011

Volltextzugriff (PDF)

Regional cerebral blood flow correlated with flashback intensity in patients with posttraumatic stress disorder

Biological psychiatry (1969), 2001-08, Vol.50 (4), p.246-253

2001

Volltextzugriff (PDF)

Effects of (+/-) 3,4-methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms

TheScientificWorld, 2007-11, Vol.7, p.231-238

2007

Volltextzugriff (PDF)

Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users

Psychopharmacology, 2011-10, Vol.217 (4), p.475-484

2011

Volltextzugriff (PDF)

Acute Effects of Zolpidem Extended-Release on Cognitive Performance and Sleep in Healthy Males After Repeated Nightly Use

Experimental and clinical psychopharmacology, 2012-02, Vol.20 (1), p.28-39

2012

Volltextzugriff (PDF)

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals

Neuropsychobiology, 2000-01, Vol.42 (1), p.5-10

2000

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(101)
Humans
(78)
Male
(75)
Biological And Medical Sciences
(65)
Medical Sciences
(60)
Psychiatry
(56)
Neurosciences & Neurology
(55)
Animals
(51)
Female
(51)
Neurosciences
(51)
Adult
(46)
Pharmacology & Pharmacy
(39)
Neurotoxicity
(34)
Psychology. Psychoanalysis. Psychiatry
(32)
Serotonin
(27)
Serotonin - Metabolism
(24)
Brain - Drug Effects
(22)
Adult And Adolescent Clinical Studies
(21)
Middle Aged
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effects of sleep deprivation on pain inhibition and spontaneous pain in women

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile

Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity

Platelet Serotonin Signaling in Patients With Cardiovascular Disease and Comorbid Depression

Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses

Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates

Plasma Drug Concentrations and Physiological Measures in 'Dance Party' Participants

Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal

Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance

Recognition and management of complications of new recreational drug use

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [ C]McN5652 and [ C]DASB

Amphetamine neurotoxicity: accomplishments and remaining challenges

Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers

Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428

Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery

Severe Dopaminergic Neurotoxicity in Primates after a Common Recreational Dose Regimen of MDMA ("Ecstasy")

Single oral doses of (±) 3,4-methylenedioxymethamphetamine (‘Ecstasy’) produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations

Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences

Regional cerebral blood flow correlated with flashback intensity in patients with posttraumatic stress disorder

Effects of (+/-) 3,4-methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms

Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users

Acute Effects of Zolpidem Extended-Release on Cognitive Performance and Sleep in Healthy Males After Repeated Nightly Use

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals

Suchergebnisse filtern